Trending NewsTrending NewsNYSE:ELV Elevance Health (ELV) Stock Price, News & Analysis $426.17 -5.83 (-1.35%) Closing price 11/6/2026 03:59 PM EasternExtended Trading$427.40 +1.24 (+0.29%) As of 11/6/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Elevance Health Stock (NYSE:ELV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Elevance Health alerts:Sign Up Key Stats Today's Range$421.47▼$430.6950-Day Range$381.68▼$445.8552-Week Range$274.84▼$450.69Volume1.44 million shsAverage Volume1.44 million shsMarket Capitalization$92.08 billionP/E Ratio18.17Dividend Yield1.61%Price Target$456.48Consensus RatingModerate Buy Company Overview Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business. Elevance Health operates primarily in the United States, with health plans serving members across multiple states and access to broader provider networks through its Blue Cross Blue Shield affiliations. Gail Boudreaux has served as the company’s president and chief executive officer since 2017.AI Generated. May Contain Errors. Read More Elevance Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreELV MarketRank™: 4.274576271185 of 5 starsElevance Health scored higher than 85% of companies evaluated by MarketBeat, and ranked 76th out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.9 / 5Analyst RatingModerate Buy Consensus RatingElevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.68, and is based on no strong buy ratings, 15 buy ratings, 7 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Elevance Health is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageElevance Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Elevance Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth2.50% Earnings GrowthEarnings for Elevance Health are expected to grow by 2.50% in the coming year, from $29.16 to $29.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Elevance Health is 18.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Elevance Health is 18.17, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.52.Price to Earnings Growth RatioElevance Health has a PEG Ratio of 1.97. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioElevance Health has a P/B Ratio of 2.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.39% of the float of Elevance Health has been sold short.Short Interest Ratio / Days to CoverElevance Health has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Elevance Health has recently increased by 5.83%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldElevance Health pays a meaningful dividend of 1.66%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthElevance Health has been increasing its dividend for 14 years.Dividend CoverageThe dividend payout ratio of Elevance Health is 29.34%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Elevance Health will have a dividend payout ratio of 23.02% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.Read more about Elevance Health's dividend. News and Social Media4.3 / 5News Sentiment0.84 News SentimentElevance Health has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 31 news articles for Elevance Health this week, compared to 8 articles on an average week.Search Interest12 people have searched for ELV on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.MarketBeat Follows5 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Elevance Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,230,336.00 in company stock.Percentage Held by Insiders0.34% of the stock of Elevance Health is held by insiders.Percentage Held by Institutions89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Elevance Health's insider trading history. Receive ELV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELV Stock News HeadlinesBernstein Keeps Their Buy Rating on Elevance Health (ELV)2 hours ago | theglobeandmail.comElevance Health (NYSE:ELV) EVP Ratnakar Lavu Sells 1,300 Shares of Company Stock3 hours ago | insidertrades.comThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.November 7 at 1:00 AM | Porter & Company (Ad)Zacks Research Raises Earnings Estimates for Elevance HealthNovember 7 at 1:59 AM | americanbankingnews.comElevance Health (NYSE:ELV) Stock Rating Upgraded by Wall Street ZenNovember 7 at 1:09 AM | americanbankingnews.comQ2 EPS Estimate for Elevance Health Lifted by AnalystNovember 6 at 2:30 AM | americanbankingnews.comWhat Needs To Be True To Buy Elevance Health Stock?November 5 at 11:02 AM | finance.yahoo.comElevance Health (NYSE:ELV) CFO Sells 10,584 Shares of Company StockOctober 24, 2026 | insidertrades.comSee More Headlines ELV Stock Analysis - Frequently Asked Questions How have ELV shares performed this year? Elevance Health's stock was trading at $350.59 at the beginning of the year. Since then, ELV shares have increased by 21.6% and is now trading at $426.1660. How were Elevance Health's earnings last quarter? Elevance Health, Inc. (NYSE:ELV) issued its quarterly earnings data on Wednesday, October, 21st. The company reported $6.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.71 by $2.28. The firm's revenue was up .7% compared to the same quarter last year. Read the conference call transcript. Does Elevance Health have any subsidiaries? Elevance Health subsidiaries include Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and more. Who are Elevance Health's major shareholders? Elevance Health's top institutional shareholders include Sanders Capital LLC (2.70%), ACR Alpine Capital Research LLC (0.43%), Russell Investments Group Ltd. (0.31%) and Sumitomo Mitsui Trust Group Inc. (0.26%). Insiders that own company stock include Gail Boudreaux, Felicia F Norwood, Mark Kaye, Ratnakar Lavu, Robert L Dixon Jr, Charles Morgan Kendrick Jr, Ramiro G Peru, Susan D Devore and Ronald W Penczek. View institutional ownership trends. How do I buy shares of Elevance Health? Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Elevance Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), UnitedHealth Group (UNH), Visa (V), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Mastercard (MA) and Advanced Micro Devices (AMD). Company Calendar Record date for 9/25 Dividend9/10/2026Ex-Dividend for 9/25 Dividend9/10/2026Dividend Payable9/25/2026Last Earnings10/21/2026Today11/07/2026Record date for 12/18 Dividend12/04/2026Ex-Dividend for 12/18 Dividend12/04/2026Dividend Payable12/18/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ELV's financial health is in the Green zone, according to TradeSmith. ELV has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:ELV CIK1156039 Webwww.elevancehealth.com Phone(800) 331-1476Fax317-488-6275Employees97,100Year Founded1944Price Target and Rating Average Price Target for Elevance Health$456.48 High Price Target$523.00 Low Price Target$360.00 Potential Upside/Downside+7.1%Consensus RatingModerate Buy Rating Score (0-4)2.68 Research Coverage22 Analysts Profitability EPS (Trailing Twelve Months)$23.45 Trailing P/E Ratio18.17 Forward P/E Ratio14.26 P/E Growth1.97Net Income$5.66 billion Net Margins2.55% Pretax Margin3.10% Return on Equity14.97% Return on Assets5.31% Debt Debt-to-Equity Ratio0.68 Current Ratio1.47 Quick Ratio1.47 Sales & Book Value Annual Sales$199.13 billion Price / Sales0.46 Cash Flow$38.71 per share Price / Cash Flow11.01 Book Value$207.33 per share Price / Book2.06Miscellaneous Outstanding Shares216,060,000Free Float215,321,000Market Cap$92.08 billion OptionableOptionable Beta0.63 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSE:ELV) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredOne Ticker Tied to a Coming 401k ChangeAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredTesla pays $0 in dividends. This new fund paid $452 in one month on $5,000.Tesla has never paid shareholders a dividend, not one cent. A new fund built on Tesla's stock takes a differen...Investors Alley | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredLast note from me on thisJoel Peterson's free workshop breaks down a three step, three color system that works across stocks, ETFs, gol...The Cycle Code | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
